Comment
. 2009 Nov;56(5):e23; author reply e24.
doi: 10.1016/j.eururo.2009.06.033.
Epub 2009 Jul 3.
Re: Hendrik Isbarn, Jehonathan H. Pinthus, Leonard S. Marks, et al. Testosterone and prostate cancer: revisiting old paradigms. Eur Urol 2009;56:48-56
- PMID: 19586711
- DOI: 10.1016/j.eururo.2009.06.033
Item in Clipboard
Comment
Re: Hendrik Isbarn, Jehonathan H. Pinthus, Leonard S. Marks, et al. Testosterone and prostate cancer: revisiting old paradigms. Eur Urol 2009;56:48-56
Eur Urol.
2009 Nov.
No abstract available
Comment on
-
Testosterone and prostate cancer: revisiting old paradigms.Eur Urol. 2009 Jul;56(1):48-56. doi: 10.1016/j.eururo.2009.03.088. Epub 2009 Apr 8. Eur Urol. 2009. PMID: 19375844 Review.
Similar articles
-
Re: Russell Szmulewitz, Supriya Mohile, Edwin Posadas, et al. A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol 2009;56:97-104.Eur Urol. 2009 Nov;56(5):e36; author reply e37. doi: 10.1016/j.eururo.2009.07.052. Epub 2009 Aug 12. Eur Urol. 2009. PMID: 19683856 No abstract available.
-
[Castration of prostate cancer patients and cognition].Duodecim. 2005;121(16):1784-5. Duodecim. 2005. PMID: 16268226 Review. Finnish. No abstract available.
-
Re: Per-Anders Abrahamsson. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49-59.Eur Urol. 2010 Jul;58(1):e4; author reply e5-6. doi: 10.1016/j.eururo.2010.03.032. Epub 2010 Mar 26. Eur Urol. 2010. PMID: 20363067 No abstract available.
-
Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leupoprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-8.Eur Urol. 2006 Sep;50(3):626-7. doi: 10.1016/j.eururo.2006.04.017. Epub 2006 May 6. Eur Urol. 2006. PMID: 16750291 No abstract available.
-
The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.BJU Int. 2005 Jun;95(9):1320-6. doi: 10.1111/j.1464-410X.2005.05526.x. BJU Int. 2005. PMID: 15892825 Review. No abstract available.
Cited by
-
Editorial Comment: Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer.Int Braz J Urol. 2022 Jan-Feb;48(1):188-195. doi: 10.1590/S1677-5538.IBJU.2022.01.08. Int Braz J Urol. 2022. PMID: 34735092 Free PMC article. No abstract available.
-
Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database.Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):236-245. doi: 10.1158/1055-9965.EPI-19-0619. Epub 2019 Oct 22. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31641011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
